Sangamo Therapeutics, Inc. Financial Ratios — SGMO Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-47.56	-26.21	-23.84	-13.76	-17.68	-38.2	-24.55	-15.58	-15.5	-15.35	-21.47	-29.94	-70.85	-73.38	-152.35
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-340.88	-99.46	-108.3	-57.19	-116.01	-369.09	-150.03	-88.56	-93.31	-98.3	-149.68	-162.37	-54.93	-154.13	-253.85
Operating Margin (%)	-347.14	-102.51	-110.66	-58.38	-118.51	-374.23	-154.13	-91.35	-102.69	-109.61	-165.61	-180.85	-67.52	-170.33	-273.07
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-170.33
Pretax Margin (%)	-346.45	-102.81	-110.32	-57.59	-117.42	-369.65	-149.23	-81.57	-93.16	-102.19	-160.79	-172.37	-149.18	-169.74	-312.25
Profit Margin (%)	-346.45	-102.81	-110.32	-57.59	-102.94	-369.58	-149.23	-80.91	-92.93	-102.37	-161.05	-172.76	-146.3	-169.45	-310.81
Net Income to Common Margin (%)	-346.45	-102.81	-110.32	-57.59	-102.94	-369.58	-149.23	-80.91	-92.93	-102.37	-161.05	-172.76	-146.3	-169.45	-310.81
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	4	25	28	44	42	48	43	38	31	27
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	3	4	4	4	5	4	2
LT Debt	- -	- -	- -	- -	- -	4	25	28	41	38	44	39	34	26	25
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.06	-0.45	-0.37	-0.46	-0.36	-0.29	-0.24	-0.39	-0.34	-0.27
Net Debt/EBITDA	0.48	1.01	0.39	0.23	1.51	0.31	0.91	1.88	0.84	1.13	1.08	0.56	0.47	0.47	0.21
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.05	-0.44	-0.36	-0.42	-0.32	-0.26	-0.21	-0.32	-0.31	-0.25
Net Debt/EBIT	0.47	0.98	0.38	0.23	1.48	0.3	0.88	1.82	0.76	1.01	0.98	0.5	0.38	0.43	0.19
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-289.36	-333.17	-214.08	-134.8	-169.65	-278.8	-172.5	-95.14	-102.87	-82.74	-132.26	-203.89	-849.62	-1,478.02	-2,717.79
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	2.9	13.17	7.54	9.52	7.72	11.74	13.22	40.43	115.3	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-0.9	-5.26	-5.19	-6.74	-5.22	-4.86	-3.53	-2.45	-1.78	-1.57
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.46	4.09	6.1	6.93	20.27	25.83	42
Total Debt/Equity (%)	- -	- -	- -	- -	- -	2.9	13.17	7.54	10.26	8.46	12.81	14.61	45.97	134.24	-187.8
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-0.9	-5.26	-5.19	-7.26	-5.72	-5.3	-3.91	-2.79	-2.08	-1.68
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.97	4.48	6.66	7.66	23.05	30.07	44.85
Net Debt to Equity	-20.92	-33.41	-8.37	-2.92	-36.11	-16.2	-26.52	-38.23	-18.59	-26.4	-47.66	-34.05	-54.54	-184.09	146.82
Net Debt/Capital (%)	6.22	7.31	3.27	1.81	15.86	4.81	9.59	20.84	11.63	15.15	16.48	8.34	3.2	2.77	1.29
EBITDA	-35	-22	-26	-26	-46	-72	-55	-75	-96	-116	-166	-181	-97	-89	-100
EBITDA-CapEx	-36	-22	-27	-26	-46	-72	-59	-118	-116	-131	-189	-201	-118	-89	-101
Operating Income (Loss)	-36	-22	-27	-27	-47	-73	-56	-77	-105	-130	-183	-201	-119	-98	-108

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	11.68	7.23	9.16	8.57	10.4	10.72	5.42	5.1	5.19	4.47	2.94	2.49	1.7	0.92	0.49
Current Ratio	11.9	7.78	9.6	9.14	10.58	11.25	5.54	5.23	5.8	4.6	3.12	2.69	1.98	1.13	0.84
Quick Ratio	11.85	7.72	9.51	9.09	10.54	11.12	5.5	5.16	5.73	4.51	2.99	2.53	1.78	1.02	0.74
CFO/Avg Current Liab	-3.62	-1.01	-2.06	-0.37	-1.65	-3.95	0.38	0.59	-1.95	1.59	-1.72	-1.87	-2.82	-1.44	-2.2
Common Equity/Total Assets	-289.36	-333.17	-214.08	-134.8	-169.65	-278.8	-172.5	-95.14	-102.87	-82.74	-132.26	-203.89	-849.62	-1,478.02	-2,717.79
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	2.9	13.17	7.54	9.52	7.72	11.74	13.22	40.43	115.3	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-0.9	-5.26	-5.19	-6.74	-5.22	-4.86	-3.53	-2.45	-1.78	-1.57
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.46	4.09	6.1	6.93	20.27	25.83	42
Total Debt/Equity (%)	- -	- -	- -	- -	- -	2.9	13.17	7.54	10.26	8.46	12.81	14.61	45.97	134.24	-187.8
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-0.9	-5.26	-5.19	-7.26	-5.72	-5.3	-3.91	-2.79	-2.08	-1.68
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.97	4.48	6.66	7.66	23.05	30.07	44.85
CFO/Total Liabilities	-359.45	-45.82	-101.85	-15.51	-135.99	-303.66	11.31	16.38	-70.52	38.5	-67.3	-83.58	-272.76	-85.13	-131.34
CFO/CapEx	-44.96	-11.18	-45.1	- -	- -	-90	2.98	0.85	-6.98	11.55	-10.02	-11.09	-10.63	-251.46	-953.02
Altman's Z-Score	7.73	6.35	21.6	15.48	13.55	1.64	5.67	1.86	1.35	1.92	-0.52	-2.99	-12.19	-21.71	-42.61

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	16.06	8.58	6.63	6.78	6.14	5.18	8.8	21.07	4.93	5.61	19.7	22.97	76.61	79.78	88.19
Days Sales Outstanding	22.73	42.54	55.08	53.8	59.49	70.53	41.5	17.32	74.09	65.06	18.53	15.89	4.76	4.58	4.14
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	143	317	777	1,019	637	215	1,281	1,113	938	2,098	1,084	485	95	206	118
- Cash & Cash Equivalents	17	22	10	6	69	22	50	140	80	131	179	100	45	42	21
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	1	- -	-1	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	4	25	28	44	42	48	43	38	31	27
Enterprise Value	59	253	685	840	428	77	1,062	741	621	1,498	756	250	52	194	124
Total Capital	-253	-275	-302	-328	-369	-436	-470	-533	-611	-735	-907	-1,104	-1,366	-1,472	-1,597
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-0.9	-5.26	-5.19	-7.26	-5.72	-5.3	-3.91	-2.79	-2.08	-1.68
Total Debt / EV	- -	- -	- -	- -	- -	0.05	0.02	0.04	0.07	0.03	0.06	0.17	0.73	0.16	0.22
EV/Sales	5.75	11.7	28.37	18.32	10.82	3.95	29.04	8.78	6.06	12.67	6.83	2.25	0.29	3.36	3.12
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	95	20.28	- -	8.82	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	71.13	9.31	- -	8.11	- -	- -	- -	- -	- -
Diluted Market Cap	143	317	777	1,019	637	215	1,281	1,113	938	2,098	1,084	485	95	206	118
Diluted Enterprise Value	127	295	767	1,013	567	197	1,255	1,001	903	2,008	953	427	88	194	124
EV per Share	1.17	4.81	12.23	12.54	6.13	1.09	13.6	7.65	5.53	11.14	5.23	1.62	0.3	0.96	0.44
TTM Sales	10	22	24	46	40	19	37	84	102	118	111	111	176	58	40
TTM EBITDA	-35	-22	-26	-26	-46	-72	-55	-75	-96	-116	-166	-181	-97	-89	-100
TTM Operating Income	-36	-22	-27	-27	-47	-73	-56	-77	-105	-130	-183	-201	-119	-98	-108
TTM Cash Flow to Firm	-26	-8	-19	-6	-34	-66	11	37	-144	170	-233	-224	-225	-67	-97
TTM Free Cash Flow to Firm	-25	-7	-19	-6	-34	-65	15	80	-124	185	-210	-203	-204	-67	-97

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-5.67	-43.07	-40.81	-179.63	-18.89	-3.3	85.77	13.98	-7.58	11.37	-5.16	-2.38	-0.47	-3.08	-1.21
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	59	253	685	840	428	77	1,062	741	621	1,498	756	250	52	194	124
Low Price	2.36	2.81	6.03	9.39	5.3	2.65	3	9	6.26	4.81	7.05	2.72	0.29	0.3	0.38
EV/Sales	5.75	11.7	28.37	18.32	10.82	3.95	29.04	8.78	6.06	12.67	6.83	2.25	0.29	3.36	3.12
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-8.01	-11.94	-20.58	-37.2	-18.89	-5.19	-13.04	-23.21	-12.15	-10.92	-8.76	-3.87	-0.97	-1.98	-1.54
Price/Earnings High	-12.93	-16.11	-30.69	-62.64	-32.99	-9.08	-26.33	-39.01	-16.38	-21.59	-14.21	-6.41	-2.54	-6.55	-3.44
Price/Earnings Low	-3.33	-6.66	-12.68	-23.82	-9.08	-2.61	-4.29	-12.77	-7.37	-5.34	-5.72	-2.18	-0.2	-0.63	-0.88
Price/Book Value	-0.57	-1.15	-2.58	-3.11	-1.73	-0.49	-2.59	-1.98	-1.43	-2.7	-1.14	-0.42	-0.07	-0.14	-0.07
Price/Book Value Average	-1.13	-0.97	-1.82	-3	-2.09	-0.85	-1.44	-2.82	-1.76	-1.7	-1.64	-0.65	-0.18	-0.13	-0.12
Price/Book Value High	-1.83	-1.3	-2.71	-5.05	-3.64	-1.48	-2.9	-4.75	-2.38	-3.36	-2.65	-1.08	-0.47	-0.43	-0.26
Price/Book Value Low	-0.47	-0.54	-1.12	-1.92	-1	-0.42	-0.47	-1.55	-1.07	-0.83	-1.07	-0.37	-0.04	-0.04	-0.07
Price/Tangible Book Value	1.79	4.88	6.57	5.02	3.34	1.6	6.87	4.08	2.76	5.29	3.85	2.34	1.14	9.04	-8.25
Price/Tangible Book Value Average	3.57	4.1	4.63	4.84	4.03	2.76	3.82	5.81	3.4	3.33	5.54	3.6	3.01	8.51	-13.26
Price/Tangible Book Value High	5.77	5.53	6.91	8.14	7.04	4.83	7.71	9.77	4.58	6.59	8.99	5.97	7.91	28.17	-29.65
Price/Tangible Book Value Low	1.49	2.28	2.85	3.1	1.94	1.39	1.26	3.2	2.06	1.63	3.62	2.03	0.61	2.69	-7.55
Price/Sales	13.9	14.64	32.22	22.22	16.11	11.1	35.02	13.18	9.16	17.75	9.79	4.35	0.54	3.56	2.98
Price/Sales Average	27.74	12.28	22.71	21.43	19.44	19.19	19.45	18.78	11.29	11.18	14.12	6.69	1.42	3.35	4.78
Price/Sales High	44.79	16.56	33.86	36.08	33.96	33.55	39.29	31.57	15.23	22.1	22.89	11.08	3.72	11.1	10.7
Price/Sales Low	11.55	6.84	13.99	13.72	9.35	9.64	6.41	10.33	6.85	5.47	9.21	3.77	0.29	1.06	2.72
Price/Cash Flow	-5.54	-39.22	-39.91	-179.63	-18.89	-3.27	114.55	30.45	-6.5	12.35	-4.65	-2.17	-0.42	-3.06	-1.21
Price/Cash Flow Average	-11.05	-32.89	-28.13	-173.18	-22.8	-5.65	63.63	43.4	-8.01	7.78	-6.7	-3.33	-1.11	-2.89	-1.95
Price/Cash Flow High	-17.85	-44.38	-41.95	-291.59	-39.82	-9.87	128.52	72.94	-10.8	15.38	-10.87	-5.51	-2.92	-9.55	-4.35
Price/Cash Flow Low	-4.6	-18.34	-17.32	-110.9	-10.96	-2.84	20.95	23.87	-4.86	3.81	-4.37	-1.88	-0.23	-0.91	-1.11
Price/Free Cash Flow Average	-11.3	-36.12	-28.77	-173.18	-22.8	-5.71	47.64	19.93	-9.35	7.16	-7.44	-3.66	-1.23	-2.9	-1.95
Price/Free Cash Flow High	-18.25	-48.73	-42.9	-291.59	-39.82	-9.98	96.23	33.48	-12.6	14.15	-12.07	-6.06	-3.22	-9.59	-4.36
Price/Free Cash Flow Low	-4.71	-20.14	-17.72	-110.9	-10.96	-2.87	15.69	10.96	-5.67	3.5	-4.85	-2.06	-0.25	-0.92	-1.11
EV/Sales Average	26.11	11.27	22.29	21.29	17.68	18.26	18.77	17.46	10.94	10.42	12.93	6.17	1.38	3.16	4.93
EV/Sales High	43.16	15.56	33.44	35.94	32.2	32.62	38.6	30.24	14.88	21.34	21.71	10.57	3.68	10.9	10.84
EV/Sales Low	9.93	5.84	13.56	13.59	7.59	8.71	5.72	9	6.5	4.71	8.03	3.26	0.25	0.86	2.87
EV/EBITDA Average	-7.66	-11.34	-20.58	-37.23	-15.24	-4.95	-12.51	-19.71	-11.73	-10.6	-8.64	-3.8	-2.51	-2.05	-1.94
EV/EBITDA High	-12.66	-15.64	-30.88	-62.85	-27.76	-8.84	-25.73	-34.15	-15.94	-21.71	-14.51	-6.51	-6.7	-7.07	-4.27
EV/EBITDA Low	-2.91	-5.87	-12.52	-23.76	-6.55	-2.36	-3.81	-10.17	-6.97	-4.79	-5.36	-2.01	-0.45	-0.56	-1.13
EV/EBIT Average	-7.52	-11	-20.14	-36.47	-14.92	-4.88	-12.18	-19.11	-10.65	-9.5	-7.81	-3.41	-2.04	-1.85	-1.81
EV/EBIT High	-12.43	-15.18	-30.22	-61.56	-27.18	-8.72	-25.05	-33.1	-14.49	-19.47	-13.11	-5.84	-5.45	-6.4	-3.97
EV/EBIT Low	-2.86	-5.7	-12.26	-23.27	-6.41	-2.33	-3.71	-9.86	-6.33	-4.3	-4.85	-1.8	-0.37	-0.51	-1.05
Last Price	2.84	6.01	13.89	15.21	9.13	3.05	16.4	11.48	8.37	15.6	7.5	3.14	0.54	1.02	0.42
High Price	9.15	6.8	14.6	24.69	19.25	9.22	18.4	27.5	13.91	19.43	17.53	7.99	3.76	3.18	1.51
Enterprise Value Average	269	244	538	977	699	354	686	1,474	1,121	1,231	1,432	687	243	182	195
Enterprise Value High	445	337	807	1,649	1,273	632	1,412	2,554	1,524	2,522	2,403	1,176	648	630	429
Enterprise Value Low	102	127	327	623	300	169	209	760	666	557	888	363	44	50	114

Shares Outstanding	53	53	62	69	70	71	86	102	116	142	146	167	178	213	351
Diluted Weighted Avg Shares	51	53	56	67	70	71	78	97	112	134	145	154	174	202	280
Basic Weighted Avg Shares	51	53	56	67	70	71	78	97	112	134	145	154	174	202	280
Revenue per Share	0.2	0.41	0.43	0.68	0.57	0.27	0.47	0.87	0.91	0.88	0.77	0.72	1.01	0.29	0.14
EBITDA per Share	-0.7	-0.41	-0.47	-0.39	-0.66	-1.01	-0.7	-0.77	-0.85	-0.86	-1.15	-1.17	-0.55	-0.44	-0.36
Operating Income per Share	-0.71	-0.42	-0.48	-0.4	-0.67	-1.03	-0.72	-0.8	-0.94	-0.96	-1.27	-1.3	-0.68	-0.49	-0.39
Basic EPS, GAAP	-0.71	-0.42	-0.48	-0.39	-0.58	-1.02	-0.7	-0.7	-0.85	-0.9	-1.23	-1.25	-1.48	-0.49	-0.44
Basic EPS from Cont Ops	-0.71	-0.42	-0.48	-0.39	-0.58	-1.02	-0.7	-0.71	-0.85	-0.9	-1.23	-1.25	-1.48	-0.49	-0.44
Diluted EPS, GAAP	-0.71	-0.42	-0.48	-0.39	-0.58	-1.02	-0.7	-0.7	-0.85	-0.9	-1.23	-1.25	-1.48	-0.49	-0.44
Diluted EPS from Cont Ops	-0.71	-0.42	-0.48	-0.39	-0.58	-1.02	-0.7	-0.71	-0.85	-0.9	-1.23	-1.25	-1.48	-0.49	-0.44
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.51	-0.15	-0.35	-0.08	-0.48	-0.93	0.14	0.38	-1.29	1.26	-1.61	-1.45	-1.29	-0.33	-0.35
Free Cash Flow per Basic Share	-0.52	-0.17	-0.36	-0.08	-0.48	-0.94	0.1	-0.07	-1.47	1.15	-1.77	-1.58	-1.41	-0.33	-0.35
Cash & Equivalents per Share	1.67	1.2	1.66	2.67	3	2.02	3.12	4.13	3.23	4.77	2.6	1.8	0.46	0.21	0.07
Book Value per Share	-5	-5.21	-5.39	-4.89	-5.28	-6.24	-6.33	-5.79	-5.85	-5.78	-6.6	-7.43	-8.05	-7.45	-5.8
Tangible Book Value per Share	1.59	1.23	2.11	3.03	2.74	1.91	2.39	2.82	3.04	2.95	1.95	1.34	0.48	0.11	-0.05

Sangamo Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)